Low physiologic oxygen tensions reduce proliferation and differentiation of human multipotent mesenchymal stromal cellsChristina Holzwarth, Ingo Müller, Martin Vaegler et al.|BMC Cell Biology|2010Cited by 307
Secretion of angiogenic proteins by human multipotent mesenchymal stromal cells and their clinical potential in the treatment of avascular osteonecrosisIngo Müller, Maximilian Rudert, Martin Vaegler et al.|Leukemia|2008Cited by 68
Tumour stromal cells derived from paediatric malignancies display MSC-like properties and impair NK cell cytotoxicityPascal-David Johann, Ingo Müller, Martin Vaegler et al.|BMC Cancer|2010Cited by 65
Long-Term Follow-Up After the Application of Mesenchymal Stromal Cells in Children and Adolescents with Steroid-Refractory Graft-Versus-Host DiseaseMichaela Döring, Ingo Müller, Karin Melanie Cabanillas Stanchi et al.|Stem Cells and Development|2021Cited by 34
Mesenchymal stromal cells: a novel treatment option for steroid-induced avascular osteonecrosis.Nikolay Tzaribachev, Ingo Müller, Martin Vaegler et al.|PubMed|2008Cited by 33